For investors
A thesis backed by fundamentals.
Positive EBITDA
A genomics business with healthy, proven unit economics.
Y-o-Y growth
Consistent year-on-year growth across services and geographies.
Largest KOL network
Anchored by globally respected key opinion leaders.
National reach
250+ cities, 3,000+ hospitals and clinics served.
Lilac Insights pairs scientific leadership with disciplined operations: positive EBITDA, year-on-year growth, and the largest KOL network in Indian clinical genomics. We are building the category leader — and we are doing it profitably.
Request the deck
Get the investor deck.
Tell us who you are and our team will share the investor deck and follow up personally.
Thank you — your request is on its way.
Our team will share the investor deck with you shortly.